A bioorthogonal click chemistry toolbox for targeted synthesis of branched and well-defined protein-protein conjugates

A highly efficient technology for protein functionalization with commonly used bioorthogonal motifs for Diels-Alder cycloaddition with inverse electron demand (DAinv). With the aim of precisely generating branched protein chimeras, we systematically assessed the reactivity, stability and side produc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Baalmann, Mathis (VerfasserIn) , Neises, Laura (VerfasserIn) , Bitsch, Sebastian (VerfasserIn) , Schneider, Hendrik (VerfasserIn) , Deweid, Ludwig Lukas (VerfasserIn) , Ilkenhans, Nadja (VerfasserIn) , Wolfring, Martin (VerfasserIn) , Ziegler, Michael J. (VerfasserIn) , Werther, Philipp (VerfasserIn) , Wilhelm, Jonas (VerfasserIn) , Kolmar, Harald (VerfasserIn) , Wombacher, Richard (VerfasserIn)
Dokumenttyp: Article (Journal) Kapitel/Artikel
Sprache:Englisch
Veröffentlicht: 2019
In: ChemRxiv
Year: 2019, Pages: ?
DOI:10.26434/chemrxiv.10743344.v1
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.26434/chemrxiv.10743344.v1
Verlag, kostenfrei, Volltext: https://chemrxiv.org/engage/chemrxiv/article-details/60c74602337d6c4b6be270aa
Volltext
Verfasserangaben:Mathis Baalmann, Laura Neises, Sebastian Bitsch, Hendrik Schneider, Lukas Deweid, Nadja Ilkenhans, Martin Wolfring, Michael J. Ziegler, Philipp Werther, Jonas Wilhelm, Harald Kolmar and Richard Wombacher
Beschreibung
Zusammenfassung:A highly efficient technology for protein functionalization with commonly used bioorthogonal motifs for Diels-Alder cycloaddition with inverse electron demand (DAinv). With the aim of precisely generating branched protein chimeras, we systematically assessed the reactivity, stability and side product formation of various bioorthogonal chemistries directly at the protein level. We demonstrate the efficiency and versatility of our conjugation platform using different functional proteins and the therapeutic antibody trastuzumab. This technology enables fast and routine access to tailored and hitherto inaccessible protein chimeras useful for a variety of scientific disciplines.
Beschreibung:Version history Nov, 26, 2019 Version 1
Gesehen am 09.11.2021
Beschreibung:Online Resource
DOI:10.26434/chemrxiv.10743344.v1